Nakahama H, Fukuhara Y, Orita Y, Yamauchi A, Takama T, Kamada T
First Department of Medicine, Osaka University Medical School, Japan.
Nephron. 1989;53(2):138-41. doi: 10.1159/000185726.
Furosemide is known to potentiate gentamicin nephrotoxicity. The mechanism of potentiation is unclear. In our previous studies, we demonstrated that furosemide enhanced gentamicin accumulation in rabbit renal tissues when injected as a bolus [Kidney int. 33:363, 1988] or repeatedly subcutaneously [Diuretics II, Elsevier, New York 1987, pp.693]. In this study, we evaluated the effects of furosemide on gentamicin accumulation in cultured renal cells (LLC-PK1) and hepatoma cells (H4IIE). Thus, we excluded effects secondary to furosemide-elicited hemodynamic changes. Seven days after seeding, the culture medium was exchanged for medium containing 1 mM gentamicin alone [G] or 1 mM gentamicin +1 mM furosemide [GF]. In LLC-PK1 cells, gentamicin concentration in [GF] was significantly higher than that in [G], while gentamicin was not detected in H4IIE cells with or without furosemide. We conclude that furosemide can accelerate gentamicin accumulation in renal tissues and potentiate gentamicin nephrotoxicity.
已知呋塞米会增强庆大霉素的肾毒性。增强作用的机制尚不清楚。在我们之前的研究中,我们证明当静脉推注[《肾脏内科》33:363, 1988]或反复皮下注射[《利尿剂II》,爱思唯尔,纽约1987年,第693页]时,呋塞米会增加庆大霉素在兔肾组织中的蓄积。在本研究中,我们评估了呋塞米对培养的肾细胞(LLC-PK1)和肝癌细胞(H4IIE)中庆大霉素蓄积的影响。因此,我们排除了呋塞米引起的血流动力学变化的继发效应。接种七天后,将培养基换成仅含1 mM庆大霉素[G]或1 mM庆大霉素 + 1 mM呋塞米[GF]的培养基。在LLC-PK1细胞中,[GF]中的庆大霉素浓度显著高于[G]中的浓度,而在有或没有呋塞米的H4IIE细胞中均未检测到庆大霉素。我们得出结论,呋塞米可加速庆大霉素在肾组织中的蓄积并增强庆大霉素的肾毒性。